SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · United Therapeutics insiders, including CEO Martine Rothblatt and CFO…

UNITED THERAPEUTICS Corp · CLUSTER filed Mar 19, 2026 at 16:30 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Mar 19, 2026 at 16:30 ET

United Therapeutics insiders, including CEO Martine Rothblatt and CFO James Edgemond, conducted a series of derivative exercises and open-market sales over the past week. The total open-market sales amounted to approximately $1.07 million, with the majority tied to option exercises at low strike prices, indicating planned equity realization rather than reactive selling.

  • CEO Martine Rothblatt sold 559 shares for $373,765 across multiple transactions at prices between $516.84 and $536.97.
  • CFO James Edgemond sold 991 shares for $527,236; also exercised 20,000 derivative shares (10,000 at $135.42, 10,000 at $0).
  • Director Tommy Thompson sold 275 shares for $147,845 and exercised 4,000 derivative shares.
  • Director Judy Olian sold 200 shares for $106,000.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access